Published in Clin Immunol on October 01, 2002
Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One (2009) 1.19
High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol (2007) 0.98
Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation (2007) 0.91
Caloric restriction and chronic inflammatory diseases. Oral Dis (2011) 0.90
Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice. J Nutr (2008) 0.82
Differential effects of energy balance on experimentally-induced colitis. World J Gastroenterol (2012) 0.80
Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci (2007) 0.80
Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease. Therap Adv Gastroenterol (2010) 0.78
The commensal microbiota exacerbate infectious colitis in stressor-exposed mice. Brain Behav Immun (2016) 0.77
Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial. World J Gastroenterol (2015) 0.77
Intrahepatic CD8(+) lymphocyte trapping during tolerance induction using mushroom derived formulations: a possible role for liver in tolerance induction. World J Gastroenterol (2008) 0.75
In case of obesity, longevity-related mechanisms lead to anti-inflammation. Age (Dordr) (2013) 0.75
Concern Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet (2002) 6.44
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant (2006) 2.20
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach. Am J Gastroenterol (2006) 2.19
Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr (2011) 1.88
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood (2002) 1.87
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol (2006) 1.86
Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. J Hepatol (2011) 1.55
Addition of essential micronutrients to foods--implication for public health policy in Israel. Isr Med Assoc J (2003) 1.43
Legislative approaches to tackling the obesity epidemic. CMAJ (2011) 1.39
AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun (2005) 1.25
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol (2005) 1.24
Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J Pharmacol Exp Ther (2006) 1.16
Public health education in a conflict area: a report from Israel. Lancet (2003) 1.16
Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. J Biol Chem (2005) 1.14
Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr (2003) 1.10
Limited English proficiency is a barrier to receipt of advice about physical activity and diet among Hispanics with chronic diseases in the United States. J Am Diet Assoc (2009) 1.05
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Am J Physiol Gastrointest Liver Physiol (2005) 1.03
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol (2009) 0.99
Familial aggregation of red blood cell membrane fatty acid composition: the Kibbutzim Family Study. Metabolism (2008) 0.98
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes. Oncology (2004) 0.97
Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol (2002) 0.97
Retracted Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol (2007) 0.96
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Int J Cancer (2003) 0.96
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp Neurol (2008) 0.96
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiol Dis (2005) 0.96
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res (2003) 0.94
Hepatic hydrothorax--pathophysiology, diagnosis and treatment--review of the literature. Liver Int (2004) 0.93
Liver abscess in inflammatory bowel disease: report of two cases and review of the literature. J Gastroenterol Hepatol (2004) 0.92
Psychosocial predictors of weight loss and psychological adjustment following bariatric surgery and a weight-loss program: the mediating role of emotional eating. Int J Eat Disord (2009) 0.92
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase. FASEB J (2007) 0.91
Gastric stimulation for weight loss. World J Gastroenterol (2012) 0.91
Late cytomegalovirus disease following liver transplantation. Transpl Int (2003) 0.91
Glycolipids as immune modulatory tools. Mini Rev Med Chem (2006) 0.91
Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer (2005) 0.90
Weight control and the management of obesity after menopause: the role of physical activity. Maturitas (2003) 0.90
Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol (2009) 0.90
Endocannabinoids and liver disease--review. Liver Int (2005) 0.89
The gut mucosa as a site for induction of regulatory T-cells. Curr Pharm Des (2009) 0.89
Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge. Am J Physiol Endocrinol Metab (2011) 0.88
Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells? Microbes Infect (2005) 0.88
Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am J Gastroenterol (2008) 0.87
Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am J Physiol Endocrinol Metab (2008) 0.87
Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol (2005) 0.87
Leptin reduces infarct size in association with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor. Curr Neurovasc Res (2010) 0.87
Animal models in the investigation of anorexia. Physiol Behav (2003) 0.86
The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin Immunol (2004) 0.86
Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins. Am J Gastroenterol (2003) 0.85
Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J Leukoc Biol (2003) 0.84
Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet (2003) 0.84
Endocannabinoids in liver disease and hepatic encephalopathy. Curr Pharm Des (2008) 0.84
Enzyme replacement therapy for mild patients with Gaucher disease. Am J Hematol (2009) 0.83
Effects of an Indo-Mediterranean diet on the omega-6/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox. World Rev Nutr Diet (2003) 0.83
Limited English proficiency is a barrier to receipt of advice about physical activity and diet among Hispanics with chronic diseases in the United States. J Am Diet Assoc (2010) 0.83
The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence? J Am Acad Dermatol (2004) 0.83
NK 1.1+ T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-gamma paradigm. J Clin Immunol (2002) 0.83
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol (2007) 0.83
beta-Glycosphingolipids as immune modulators. J Immunotoxicol (2008) 0.83
Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav (2004) 0.83
The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells. Neurobiol Dis (2007) 0.82
The effect of vitamin C on upper respiratory infections in adolescent swimmers: a randomized trial. Eur J Pediatr (2010) 0.82
Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis. Inflamm Bowel Dis (2003) 0.82
The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats. Nutr Neurosci (2003) 0.82
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J Inflamm Res (2012) 0.82
Induction of immune tolerance: a role for Natural killer T lymphocytes? Liver Int (2005) 0.81
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull (2005) 0.81
Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J (2010) 0.81
Prevalence and determinants of physical activity and lifestyle in relation to obesity among schoolchildren in Israel. Public Health Nutr (2008) 0.81
Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial. Liver Int (2004) 0.81
Modulation of intracellular machinery by beta-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis. Mol Immunol (2008) 0.81
A novel 13C-urea breath test device for the diagnosis of Helicobacter pylori infection: continuous online measurements allow for faster test results with high accuracy. J Clin Gastroenterol (2003) 0.81
The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer (2002) 0.81
Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology. J Breath Res (2009) 0.80
Determinants of disordered eating behaviors among Israeli adolescent girls. Eat Disord (2008) 0.80
Dietary approaches to obesity. Mt Sinai J Med (2010) 0.80
[Who will take care of the caretaker? Lifestyle recommendations for physicians]. Harefuah (2011) 0.80
Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models. Dig Dis Sci (2010) 0.80
The dietary treatment of obesity. Med Clin North Am (2011) 0.80
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int J Cancer (2002) 0.80
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping. J Lipid Res (2008) 0.80
Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol (2003) 0.80
Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation (2004) 0.79
Air transportation of patients with end-stage liver disease to distant liver transplantation centers. Liver Transpl (2005) 0.79
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. Prostaglandins Leukot Essent Fatty Acids (2008) 0.79